ALB and neoplasm: The baseline characteristics, including sex, age, tumor location, stage, family history, ECOG, albumin, CA-19.9 and 1L chemotherapy regimens, platinum-based or platinum-free chemotherapy were not significantly different between patients with or without gHRmut (Table 3).